Ptc Therapeutics (PTCT) Operating Income Growth (1y) (2013 - 2026)
Ptc Therapeutics (PTCT) Operating Income Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | - |
| 4 | BeOne Medicines | 469.11 Bn | 464.32 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 123.03 Bn | 115.78 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.37 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 63.44 Bn | 63.44 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 1,386.07% |
| 10 | Ptc Therapeutics | 6.32 Bn | 4.43 Bn | 244.52 Mn | -95.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95.37% |
| Dec 31, 2025 | 56.06% |
| Sep 30, 2025 | 105.53% |
| Jun 30, 2025 | 13.08% |
| Mar 31, 2025 | 2,234.57% |
| Dec 31, 2024 | -2,890.19% |
| Sep 30, 2024 | 53.87% |
| Jun 30, 2024 | 80.81% |
| Mar 31, 2024 | 61.35% |
| Dec 31, 2023 | 102.91% |
| Sep 30, 2023 | -73.29% |
| Jun 30, 2023 | -126.87% |
| Mar 31, 2023 | -35.94% |
| Dec 31, 2022 | -136.45% |
| Sep 30, 2022 | 26.74% |
| Jun 30, 2022 | 6.22% |
| Mar 31, 2022 | 11.85% |
| Dec 31, 2021 | 12.08% |
| Sep 30, 2021 | -68.83% |
| Jun 30, 2021 | 47.41% |